Effects of Kinesio Taping Techniques in COPD Patients

Not Applicable

Completed

• Conditions: Chronic Obstructive Pulmonary Disease
• Interventions: Device: Kinesio Taping

• Registration Number: NCT04241510
• Lead Sponsor: Muğla Sıtkı Koçman University

Brief Summary

Study will investigate effects of two different kinesio taping techniques on pulmonary parameters of patients with COPD.

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) is an irreversible, progressive, treatable airway disease which causes dyspnea, wheezing, coughing and increased secretions in airways. Thoracic and respiratory mechanics are impaired, respiratory muscle strength and functional exercise capacity is decreased in patients with COPD. As a result dyspnea, limitation in activities of daily living, postural impairments, muscle length-strength relationship changes and increased mechanical loads on respiratory muscles occur. In literature it has been demonstrated that Kinesio Taping have therapeutic effects on respiratory functions and functional exercise capacity in patients with chronic neurological diseases who has additional respiratory impairments. Although there are several studies in literature investigating the effects of facilitation and inhibition taping techniques applied on respiratory muscles in patients with COPD, effects of thoracic and postural mechanical correction techniques as an alternative treatment modality in patients with COPD have not been investigated yet. In present study, effects of thoracic mechanical correction and facilitation taping techniques in patients with COPD will be investigated, and data will be collected for effects of thoracic mechanical correction taping on pulmonary parameters in patients with COPD.

Study Timeline

• Study First Submitted: 2020-01-22
• Study First Submitted QC: 2020-01-22
• Study First Posted: 2020-01-27
• Study Start: 2022-04-20
• Status Verified: 2022-10
• Primary Completion: 2022-10-31
• Study Completion: 2022-10-31
• Last Update Submitted: 2022-10-31
• Last Update Posted: 2022-11-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

• Male and female COPD patients aged between 40-80 years
• Diagnosed with COPD stage I-II-III-IV according to GOLD 2019 criterias
• Able to speak, understand and read Turkish language
• Volunteering to participate in study

Exclusion Criteria

• Unstable or acutely exacerbated patients with COPD
• Alterations in medical treatment in last 6 months
• Having comorbidities that affect directly cardiopulmonary system, uncontrolled arterial hypertension, severe congestive heart failure, coronary arterial disease, heart valve disease
• Orthopaedic, neurological, psychiatric disease, peripheral/central nervous system diseases, mental retardation, antidepressants usage, metabolic impairments, malignancy
• Unable to cooperate for measurement and treatment techniques used in study
• Irritation, infection, allergic reaction, scarred burn or open wound around application area
• Enrolled in a comprehensive pulmonary rehabilitation program before study
• Application of Kinesio Tape to any body region in the past
• History of an open heart surgery or other thoracic surgeries

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Facilitation Tape	Kinesio Taping	Diaphragm and Intercostal muscles will be taped with facilitation technique. After 30 minutes of application patients will be evaulated for pulmonary parameters, functional exercise capacity and dyspnea.
Mechanical Correction Tape	Kinesio Taping	Thorax will be taped with mechanical correction technique. After 30 minutes of application patients will be evaulated for pulmonary parameters, functional exercise capacity and dyspnea.

Primary Outcome Measures

Name	Time	Method
Pulmonary Function Test	30 minutes after every application	Pulmonary functions will be evaulated in laboratory conditions. Dynamic lung volumes will be measured using standardized spirometric measurement regulations established by ATS/ERS guidelines.
Respiratory Muscle Strength	30 minutes after every application	Respiratory muscle strenght will be measured as Maximum Inspiratory Pressure \& Maximum Expiratory Pressure with MicroMPM device. Measuring procedure will be held according to ERS guidelines. Measurements will be interpreted with Black and Hyatt's references.
Functional Exercise Capacity	30 minutes after every application	Functional exercise capacity will be measured with 6-minute walk test. Cardiovascular paremeters, dyspnea, respiratory rate and fatigue will be evaulated before, during and after the test .
Dyspnea	30 minutes after each application	Dyspnea in daily living was evaluated by the Modified Medical Research Council Dyspnea Scale. The scale consists in five statements that describe almost the entire range of dyspnea from none (Grade 0) to almost complete incapacity (Grade 4). Higher scores indicates increased dyspnea perception.

Secondary Outcome Measures

Name	Time	Method
Perception of Disease	30 minutes after each application.	COPD Assesment Test (CAT) will be used to evaulate patients perception of symptoms.

Trial Locations

Locations (1)

Muğla Sıtkı Koçman University Training and Research Hospital; 🇹🇷 Muğla, Menteşe, Turkey